Logiscreen

Harvard Bioscience Inc

$5.92
Market Cap 26.47M
ROE -73.0%
Gross Margin 59.0%
Debt/Equity 4.2
Current Ratio 2.0
Revenue QoQ -4.7%
EPS QoQ -0.9%
F-Score 2

About

Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.

Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Instruments & Supplies

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-2.81
vs median 36.93
P/B
2.73
vs median 2.32
ROE
-0.73
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics